Cover Image

The changes in the level of cytokines, glomerotubular markers, cardiohemodynamics in chronic heart failure and its combination with kidney disease

Saved in:

Bibliographic Details
Date:	2012
Main Authors:	P. G. Kravchun, Ju. A. Mikhajlova, L. A. Lapshina, O. V. Petjunina
Format:	Article
Language:	English
Published:	2012
Series:	International medical journal
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0000037044
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

The state of the pro-inflammatory cytokine level in patients with unstable angina and type 2 diabetes mellitus depending on functional class of chronic heart failure
by: A. N. Belovol, et al.
Published: (2013)

Correction of hyperglycemia, a predictor of endothelial dysfunction in petients with chronic heart failure
by: S. A. Krapivko, et al.
Published: (2017)

The oxidative status in patients with chronic kidney disease
by: V. S. Vasylchenko, et al.
Published: (2020)

Chronic kidney disease in children: supranosological and nosological approaches
by: N. I. Makeeva
Published: (2013)

Features of cardiohaemodynamics of patients with ischemic heart disease and arterial hypertension when the amlodipine included in complex treatment of chronic heart failure
by: Yu. Ilikchiieva
Published: (2017)

Analysis of genetic factors in patients with chronic heart failure
by: T. V. Martynovich, et al.
Published: (2014)

Clinical and therapeutic value of adipokines in patients with chronic kidney disease
by: Ya. M. Fylenko
Published: (2020)

Role of renal functional reserve in the diagnosis and monitoring of chronic kidney disease
by: A. I. Gozhenko, et al.
Published: (2017)

Immunohistochemical features of spleen in pneumonia arisen on the background chronic heart failure
by: E. A. Pavlova
Published: (2015)

Dynamics of functional state of kidneys in patients with resistant hypertension and chronic kidney disease according to long-term follow-up
by: L. A. Mishchenko, et al.
Published: (2020)

The intensity of lipid distress syndrome in patients with non- alcoholic fatty liver disease on the background of obesity and chronic kidney disease (chronic pyelonephritis)
by: O. S. Khukhlina, et al.
Published: (2019)

Survival predictors in elderly patients with chronic ischemic heart disease
by: A. L. Filipiuk, et al.
Published: (2012)

Features of the course of the chronic rheumatic heart disease in modern conditions
by: O. O. Yakymenko, et al.
Published: (2019)

Chronic rheumatic heart disease and environmental pollution degree of atmosphere
by: G. S. Taktashov
Published: (2016)

Dynamics of changes of galectin-3 level in patients with chronic heart failure at six-month observation
by: V. J. Tselujko, et al.
Published: (2013)

Relationship between circulating levels of osteoprotegerin and insulin resistance in patients with ischemic chronic heart failure
by: A. A. Kremzer
Published: (2014)

The role of microelementosis in pathogenesis of respiratory disorders at chronic rheumatic heart disease
by: G. S. Taktashov
Published: (2015)

D-dimer as a potential predictor of thromboembolic and cardiovascular complications in patients with chronic kidney disease
by: I. S. Mykhaloiko, et al.
Published: (2020)

Morphofunctional changes in the kidneys with renal failure (Review)
by: A. I. Hozhenko, et al.
Published: (2018)

Dynamics of changes of inflammation indicators in patients with community-acquired pneumonia and concomitant chronic heart failure
by: I. H. Berezniakov, et al.
Published: (2017)

Effect of immunomodulating therapy on the condition of specific humoral immunity in the progression of chronic kidney disease in patients with IHD
by: O. O. Pavlova
Published: (2019)

The functional status and remodeling of left ventricle in chronic heart failure in men depending on the degree of excess weight
by: P. P. Bidzilia
Published: (2016)

Cardiohemodynamics and efficiency of Frank–Starling mechanism during aging
by: N. O. Dorofeieva, et al.
Published: (2014)

Application of &quot;L-BIOCOMPLEX&quot; in chronic heart failure treatment in patients with metabolic syndrome
by: O. M. Korzh, et al.
Published: (2021)

The content of procalcitonin and galectin-3 in the blood of patients with community-acquired pneumonia and concomitant chronic heart failure and without it
by: V. I. Bereznjakov, et al.
Published: (2015)

Concomitant coronary heart disease as a factor in reducing the quality of life of patients with chronic pancreatitis
by: L. S. Babinets, et al.
Published: (2019)

Peculiarities of the comorbidity structure and combined pharmacotherapy in ischemic heart disease combined with primary hypertension in the elderly age
by: V. A. Shtanko, et al.
Published: (2013)

Levels of malondialdehyde and magnesium and the activity of catalase and glutathione reductase as markers of oxidative stress in the erythrocytes of patients with Ischemic Heart Disease
by: Chachoua, I., et al.
Published: (2010)

Clinical characteristics of patients with chronic heart failure and type 2 diabetes mellitus who require implantation of permanent pacemaker
by: O. S. Voronenko, et al.
Published: (2021)

Formation, assessment and correction of cognitive disorders in patients with comorbid chronic obstructive pulmonary and coronary heart diseases
by: H. S. Isaieva, et al.
Published: (2021)

Concentration of kidney function in patients with impaired left ventri¬cu¬lar systolic function in the back¬ground of coronary heart disease and hypertension
by: A. I. Hozhenko, et al.
Published: (2015)

Rationale for the differentiated appointment of vazoactive preparations in the treatment of patients with ischemic heart disease in combination with arterial hypertension dependent on the degree of pulmonary hypertension and / or the stage of chronic hear
by: N. A. Matsehora, et al.
Published: (2017)

COVID-19 infection: disease mechanism, vascular dysfunction, immune responses, markers, multiorgan failure, treatments, and vaccination
by: S. G. Vari
Published: (2020)

Prediction of the development of chronic coronary heart disease in patients with metabolic syndrome at obesity considered age and gender features
by: N. Chmyr
Published: (2018)

Correction of pharmacological treatment of patients with arterial hypertension in combination with chronic obstructive pulmonary disease
by: O. M. Vlasenko, et al.
Published: (2021)

Structural and functional myocardial changes in patients with chronic obstructive pulmonary disease combined with hypertension
by: V. A. Kapustnyk, et al.
Published: (2018)

Іnfluence of excessive body mass on formation of systemic proinflammatory cytokine potential in patients with purulent-destructive forms of chronic nonspecific pulmonary diseases
by: Mindrul, M.A.
Published: (2013)

The use of alpha-lipoic acid in patients with chronic acalculous cholecystitis in combination with coronary artery disease
by: K. N. Kompaniets
Published: (2016)

The role of apoptosis in the combined course of chronic obstructive pulmonary disease and type 2 diabetes mellitus
by: N. K. Sukhonos
Published: (2017)

The role of stress in heart failure – ground for sex specific pathophysiology
by: Heffer, M., et al.
Published: (2011)